Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Stephanie Harris

Showing results (51-60 of 54) with videos related to

Pageof 6
Sort By:
You have reached the last page of results.This site can display upto 54 results.
Annals of Internal Medicine|July 14, 2025
Evaluation of a Region-Wide Hospital-Based Violence Intervention Program : A Pilot Cohort StudyKristen L Mueller, Taylor M Kaser, Benjamin P Cooper, et al.
BMJ Open|November 22, 2011
A Phase I study evaluating the safety and immunogenicity of MVA85A, a candidate TB vaccine, in HIV-infected adultsAngela M Minassian, Rosalind Rowland, Natalie E R Beveridge, et al.
Nature Communications|September 30, 2022
Publisher Correction: Endophenotype effect sizes support variant pathogenicity in monogenic disease susceptibility genesJennifer L Halford, Valerie N Morrill, Seung Hoan Choi, et al.
Nature Communications|August 30, 2022
Endophenotype effect sizes support variant pathogenicity in monogenic disease susceptibility genesJennifer L Halford, Valerie N Morrill, Seung Hoan Choi, et al.
Pageof 6

Showing results (51-60 of 54) with videos related to

Sort By:
Pageof 6
You have reached the last page of results.This site can display upto 54 results.
Annals of Internal Medicine|July 14, 2025
Evaluation of a Region-Wide Hospital-Based Violence Intervention Program : A Pilot Cohort StudyKristen L Mueller, Taylor M Kaser, Benjamin P Cooper, et al.
BMJ Open|November 22, 2011
A Phase I study evaluating the safety and immunogenicity of MVA85A, a candidate TB vaccine, in HIV-infected adultsAngela M Minassian, Rosalind Rowland, Natalie E R Beveridge, et al.
Nature Communications|September 30, 2022
Publisher Correction: Endophenotype effect sizes support variant pathogenicity in monogenic disease susceptibility genesJennifer L Halford, Valerie N Morrill, Seung Hoan Choi, et al.
Nature Communications|August 30, 2022
Endophenotype effect sizes support variant pathogenicity in monogenic disease susceptibility genesJennifer L Halford, Valerie N Morrill, Seung Hoan Choi, et al.
Pageof 6